Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2012
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471557A1 A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid useful for the localization of radionuclides for diagnostic and therapeutic purposes
07/04/2012EP2471555A2 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
07/04/2012EP2471548A1 siRNA against Cbl-b and optionally IL2 and IL12 for use in the treatment of cancer
07/04/2012EP2471547A1 Apoptosis inducer
07/04/2012EP2471544A1 Agent for reducing risk of developing cancer
07/04/2012EP2471510A1 Liquid formulation of G-CSF
07/04/2012EP2470655A1 Development of universal cancer drugs and vaccines
07/04/2012EP2470652A1 Ercc6l as target genes for cancer therapy and diagnosis
07/04/2012EP2470650A1 Breast cancer related gene c12orf32
07/04/2012EP2470567A1 Humanized anti-cdcp1 antibodies
07/04/2012EP2470550A1 Bisphosphonates as inhibitors of acid sphingomyelinase
07/04/2012EP2470547A1 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents
07/04/2012EP2470544A1 Condensed quinolines as protein kinase modulators
07/04/2012EP2470541A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470539A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470538A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470537A2 Heterocyclic compounds as janus kinase inhibitors
07/04/2012EP2470532A1 1h-pyrazolo [ 3, 4-b]pyridine compounds for inhibiting raf kinase
07/04/2012EP2470528A1 Compounds and compositions as protein kinase inhibitors
07/04/2012EP2470526A1 Compounds and compositions as protein kinase inhibitors
07/04/2012EP2470522A1 Np-1 antagonists and their therapeutic use
07/04/2012EP2470515A2 Desferrithiocin polyether analogues and uses thereof
07/04/2012EP2470512A1 Aromatase inhibitor
07/04/2012EP2470511A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470506A1 Kinase inhibitors
07/04/2012EP2470499A1 Novel colchicine derivatives, methods and uses thereof
07/04/2012EP2470217A1 Targeting pax2 for the treatment of breast cancer
07/04/2012EP2470215A2 Bisphosphonate-prodrugs
07/04/2012EP2470212A1 Method of treatment of philadelphia chromosome positive leukaemia
07/04/2012EP2470206A1 Antibodies against cdcp1 for the treatment of cancer
07/04/2012EP2470186A2 Synthesis and isolation of dendrimer systems
07/04/2012EP2470179A2 Sustained release delivery systems for the prevention and treatment of head and neck cancers
07/04/2012EP2470177A1 Combination therapy for treating proliferative diseases
07/04/2012EP2470170A2 Use of metformin in cancer treatment and prevention
07/04/2012EP2470169A2 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10)
07/04/2012EP2285416B1 Conjugates for the treatment of mesothelioma
07/04/2012EP2178888B1 Proteasome inhibitors
07/04/2012EP2062887B1 Aminopyridine derivative having aurora a-selective inhibitory activity
07/04/2012EP2015748B1 A C-Kit kinase inhibitor for use in the treatment of gastrointestinal stromal tumor or mastocytosis
07/04/2012EP2004649B1 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
07/04/2012EP1989206B1 Inhibitors of e1 activating enzyme
07/04/2012EP1874306B1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
07/04/2012EP1786799B1 Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
07/04/2012EP1758610B1 Methods of treating cancer using il-21 and monoclonal antibody therapy
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012EP1556410B1 Peptide fragments of the harp factor inhibiting angiogenesis
07/04/2012EP1550662B1 Adenine compound and use thereof
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1953965B Novel cis-imidazolines
07/04/2012CN1863817B Antibodies to M-CSF
07/04/2012CN1842540B Anti-glypican 3 antibody
07/04/2012CN1809557B Compound
07/04/2012CN1668613B Flavone derivatives of inhibitors of cyclin-dependent kinases
07/04/2012CN102549015A High affinity human antibodies to human angiopoietin-2
07/04/2012CN102549014A Human serum amyloid-A3 antibody and use thereof
07/04/2012CN102548995A Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
07/04/2012CN102548992A 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
07/04/2012CN102548987A Fluoro-substituted compounds as kinase inhibitors and methods of use thereof
07/04/2012CN102548984A Inhibitors of PI3 kinase and / or MTOR
07/04/2012CN102548975A Histone deacetylase inhibitors
07/04/2012CN102548974A Novel FXR (NR1H4 ) binding and activity modulating compounds
07/04/2012CN102548970A Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as AKT (PKB) phosphorylation inhibitors
07/04/2012CN102548965A 取代酰胺化合物 Substituted amide compounds
07/04/2012CN102548963A Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
07/04/2012CN102548945A Apogossypolone derivatives as anticancer agents
07/04/2012CN102548565A Agent for reducing risk of developing cancer
07/04/2012CN102548549A Methods for treatment of a sarcoma using an epimetabolic shifter (Coenzyme Q10)
07/04/2012CN102548539A Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
07/04/2012CN102534003A Applications of human pre-B-cell leukemia homeobox 1 (PBX1) gene and related drugs thereof
07/04/2012CN102533996A Method for determining APRIL (A Proliferation-inducing Ligand) gene promoter and transcription factor binding site and use
07/04/2012CN102533982A New use of human gene KLF8 in tumor treatment
07/04/2012CN102533966A Micro-RNA-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
07/04/2012CN102533917A Method for preparing RGD (arginine glycine aspartate) active polypeptide from collagen
07/04/2012CN102533858A Tumor-specific replication-competent adenovirus anti-tumor preparation
07/04/2012CN102533830A Immune gene therapy plasmid cooperatively expressed by alpha fetal protein (AFP) epitope peptide and IL-15
07/04/2012CN102533828A Recombinant plasmid and virus of tissue specificity and application thereof.
07/04/2012CN102533787A Peganum harmala lipid transfer protein gene, and recombination expression and application thereof
07/04/2012CN102533771A Anti-tumor angiogenesis aptamer molecule and preparation method thereof
07/04/2012CN102533770A Nucleic acid molecule and application thereof
07/04/2012CN102533763A Construction and use of lentivirus-mediated siRNA (small interfering RNA) recombinant 970 against VEGF-C (vascular endothelial growth factor C) gene
07/04/2012CN102533755A Human miR-328 antisense nucleic acid and application thereof
07/04/2012CN102533661A Human embryonic stem cell-derived endothelial cell from with functions of tumor targeting, in-vivo tracking and tumor treating
07/04/2012CN102533653A 5-HT nerve cells induced by MSCs and ASCs and microencapsulation preparation method and application thereof
07/04/2012CN102533569A Separation screening method of paper mulberry endophytic fungi and application thereof
07/04/2012CN102532345A O-unsaturated fatty acid acylated chitosan oligosaccharides as well as preparation and application thereof
07/04/2012CN102532339A Method for selenizing pilose asiabell root polysaccharides and application of product
07/04/2012CN102532337A Method for producing glycyrrhizia polysaccharide by utilizing tissue culture method
07/04/2012CN102532326A Tumor-targeted plasminogen Kringle5 variant and application thereof
07/04/2012CN102532320A Single-chain antibody of fully-human anti-human interleukin-21 receptor and application thereof
07/04/2012CN102532319A Anti-bFGF (Basic Fibroblast Growth Factor) humanized double-stranded antibody with stable disulfide bonds, and preparation method and application thereof
07/04/2012CN102532317A Monoclonal antibody of PES1 and application thereof
07/04/2012CN102532314A Preparation method and medical application antibody against tumor associated antigen of Trichinella spiralis
07/04/2012CN102532313A p28GANK monoclonal antibody and application thereof
07/04/2012CN102532269A Dominant sequence of delta 1 chain complementary determining region (CDR) 3 in gamma delta T lymphocytes, and T cell receptor (TCR) transfected cells and application thereof
07/04/2012CN102532268A Oligopeptide with breast cancer resistant activity and application thereof
07/04/2012CN102532265A Gramicidin, isomer thereof and application thereof
07/04/2012CN102532264A Peptide-based compounds
07/04/2012CN102532263A Bi-component drug micromolecule hydrogel based on hexadecadrol and taxol and preparation method thereof
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 2211